Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2015, Article ID 802939, 8 pages
http://dx.doi.org/10.1155/2015/802939
Research Article

Decreased IL-27 Negatively Correlated with Th17 Cells in Non-Small-Cell Lung Cancer Patients

1Department of Respiratory Medicine, The Eighth People’s Hospital of Nanning, Nanning, Guangxi 530001, China
2Department of Respiratory Medicine, The First People’s Hospital of Nanning, Nanning, Guangxi 530001, China
3Department of Respiratory Medicine, The First Affiliated Hospital, Guangxi Medical University, Nanning, Guangxi 530021, China

Received 11 January 2015; Accepted 22 March 2015

Academic Editor: Kathy Triantafilou

Copyright © 2015 Minchao Duan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. S. Ettinger, D. E. Wood, W. Akerley et al., “Non-small cell lung cancer, version 1.2015,” Journal of the National Comprehensive Cancer Network, vol. 12, no. 12, pp. 1738–1761, 2014. View at Google Scholar
  2. A. J. Alberg, M. V. Brock, J. G. Ford, J. M. Samet, and S. D. Spivack, “Epidemiology of lung cancer: diagnosis and management of lung cancer, 3rd ed: American college of chest physicians evidence-based clinical practice guidelines,” Chest, vol. 143, no. 5, supplement, pp. e1S–e29S, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. J. Ellis, “The impact of lung cancer on patients and carers,” Chronic Respiratory Disease, vol. 9, no. 1, pp. 39–47, 2012. View at Publisher · View at Google Scholar
  4. S. L. Reiner, “Development in motion: helper T cells at work,” Cell, vol. 129, no. 1, pp. 33–36, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. C. T. Weaver and R. D. Hatton, “Interplay between the TH17 and TReg cell lineages: a (co-) evolutionary perspective,” Nature Reviews Immunology, vol. 9, no. 12, pp. 883–889, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. A. K. Abbas, K. M. Murphy, and A. Sher, “Functional diversity of helper T lymphocytes,” Nature, vol. 383, no. 6603, pp. 787–793, 1996. View at Publisher · View at Google Scholar · View at Scopus
  7. N. Ito, H. Nakamura, Y. Tanaka, and S. Ohgi, “Lung carcinoma: analysis of T helper type 1 and 2 cells and T cytotoxic type 1 and 2 cells by intracellular cytokine detection with flow cytometry,” Cancer, vol. 85, no. 11, pp. 2359–2367, 1999. View at Publisher · View at Google Scholar · View at Scopus
  8. R. P. Singh, S. Hasan, S. Sharma et al., “Th17 cells in inflammation and autoimmunity,” Autoimmunity Reviews, vol. 13, no. 12, pp. 1174–1181, 2014. View at Google Scholar
  9. T. Korn, E. Bettelli, M. Oukka, and V. K. Kuchroo, “IL-17 and Th17 cells,” Annual Review of Immunology, vol. 27, pp. 485–517, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. J.-W. Du, K.-Y. Xu, L.-Y. Fang, and X.-L. Qi, “Interleukin-17, produced by lymphocytes, promotes tumor growth and angiogenesis in a mouse model of breast cancer,” Molecular Medicine Reports, vol. 6, no. 5, pp. 1099–1102, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. Q. Li, Y. Han, G. Fei, Z. Guo, T. Ren, and Z. Liu, “IL-17 promoted metastasis of non-small-cell lung cancer cells,” Immunology Letters, vol. 148, no. 2, pp. 144–150, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. I. Kryczek, S. Wei, W. Szeliga, L. Vatan, and W. Zou, “Endogenous IL-17 contributes to reduced tumor growth and metastasis,” Blood, vol. 114, no. 2, pp. 357–359, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. N. Martin-Orozco, P. Muranski, Y. Chung et al., “T helper 17 cells promote cytotoxic T cell activation in tumor immunity,” Immunity, vol. 31, no. 5, pp. 787–798, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. S. Pflanz, J. C. Timans, J. Cheung et al., “IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4+ T cells,” Immunity, vol. 16, no. 6, pp. 779–790, 2002. View at Publisher · View at Google Scholar · View at Scopus
  15. S. Pflanz, L. Hibbert, J. Mattson et al., “WSX-1 and glycoprotein 130 constitute a signal-transducing receptor for IL-27,” The Journal of Immunology, vol. 172, no. 4, pp. 2225–2231, 2004. View at Publisher · View at Google Scholar · View at Scopus
  16. C. A. Hunter, “New IL-12-family members: IL-23 and IL-27, cytokines with divergent functions,” Nature Reviews Immunology, vol. 5, no. 7, pp. 521–531, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. J. Colgan and P. Rothman, “All in the family: IL-27 suppression of TH-17 cells,” Nature Immunology, vol. 7, no. 9, pp. 899–901, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. H. Yoshida and M. Yoshiyuki, “Regulation of immune responses by interleukin-27,” Immunological Reviews, vol. 226, no. 1, pp. 234–247, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Hisada, S. Kamiya, K. Fujita et al., “Potent antitumor activity of interleukin-27,” Cancer Research, vol. 64, no. 3, pp. 1152–1156, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. S. Oniki, H. Nagai, T. Horikawa et al., “Interleukin-23 and interleukin-27 exert quite different antitumor and vaccine effects on poorly immunogenic melanoma,” Cancer Research, vol. 66, no. 12, pp. 6395–6404, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. C. Diveu, M. J. McGeachy, K. Boniface et al., “IL-27 blocks RORc expression to inhibit lineage commitment of Th17 cells,” Journal of Immunology, vol. 182, no. 9, pp. 5748–5756, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. E. Di Carlo, C. Sorrentino, A. Zorzoli et al., “The antitumor potential of Interleukin-27 in prostate cancer,” Oncotarget, vol. 5, no. 21, pp. 10332–10341, 2014. View at Google Scholar
  23. K.-L. Liao, X.-F. Bai, and A. Friedman, “Mathematical modeling of Interleukin-27 induction of anti-tumor T cells response,” PLoS ONE, vol. 9, no. 3, Article ID e91844, 2014. View at Publisher · View at Google Scholar · View at Scopus
  24. K. Nistala, H. Moncrieffe, K. R. Newton, H. Varsani, P. Hunter, and L. R. Wedderburn, “Interleukin-17-producing T cells are enriched in the joints of children with arthritis, but have a reciprocal relationship to regulatory T cell numbers,” Arthritis & Rheumatism, vol. 58, no. 3, pp. 875–887, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. J. S. Tzartos, M. A. Friese, M. J. Craner et al., “Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis,” American Journal of Pathology, vol. 172, no. 1, pp. 146–155, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. S. AlFadhli, A. AlFailakawi, and A. A. Ghanem, “Th-17 related regulatory network in the pathogenesis of Arab patients with systemic lupus erythematosus and lupus nephritis,” International Journal of Rheumatic Diseases, 2014. View at Publisher · View at Google Scholar
  27. L. Zhao, J. Yang, H.-P. Wang, and R.-Y. Liu, “Imbalance in the Th17/Treg and cytokine environment in peripheral blood of patients with adenocarcinoma and squamous cell carcinoma,” Medical Oncology, vol. 30, no. 1, article 461, 2013. View at Publisher · View at Google Scholar · View at Scopus
  28. Z.-J. Ye, Q. Zhou, Y.-Y. Gu et al., “Generation and differentiation of IL-17-producing CD4+ T cells in malignant pleural effusion,” Journal of Immunology, vol. 185, no. 10, pp. 6348–6354, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. S. Li, Y. Li, X. Qu, X. Liu, and J. Liang, “Detection and significance of TregFoxP3+and Th17 cells in peripheral blood of non-small cell lung cancer patients,” Archives of Medical Science, vol. 10, no. 2, pp. 232–239, 2014. View at Publisher · View at Google Scholar · View at Scopus
  30. R. Li, D. Rüttinger, L. S. Si, and Y. L. Wang, “Analysis of the immunological microenvironment at the tumor site in patients with non-small cell lung cancer,” Langenbeck's Archives of Surgery, vol. 388, no. 6, pp. 406–412, 2003. View at Publisher · View at Google Scholar · View at Scopus
  31. Y. Li, Z. Y. Cao, B. Sun et al., “Effects of IL-17A on the occurrence of lung adenocarcinoma,” Cancer Biology & Therapy, vol. 12, no. 7, pp. 610–616, 2011. View at Google Scholar
  32. M. Numasaki, M. Watanabe, T. Suzuki et al., “IL-17 enhances the net angiogenic activity and in vivo growth of human non-small cell lung cancer in SCID mice through promoting CXCR-2-dependent angiogenesis,” Journal of Immunology, vol. 175, no. 9, pp. 6177–6189, 2005. View at Publisher · View at Google Scholar · View at Scopus
  33. K. Hirahara, K. Ghoreschi, X.-P. Yang et al., “nterleukin-27 priming of T cells controls IL-17 production in trans via induction of the ligand PD-L1,” Immunity, vol. 36, no. 6, pp. 1017–1030, 2012. View at Publisher · View at Google Scholar · View at Scopus
  34. G. Murugaiyan, A. Mittal, R. Lopez-Diego, L. M. Maier, D. E. Anderson, and H. L. Weiner, “IL-27 is a key regulator of IL-10 and IL-17 production by human CD4+ T cells,” The Journal of Immunology, vol. 183, no. 4, pp. 2435–2443, 2009. View at Publisher · View at Google Scholar · View at Scopus
  35. P. Kachroo, M.-H. Lee, L. Zhang et al., “IL-27 inhibits epithelial-mesenchymal transition and angiogenic factor production in a STAT1-dominant pathway in human non-small cell lung cancer,” Journal of Experimental and Clinical Cancer Research, vol. 32, no. 1, article 97, 2013. View at Publisher · View at Google Scholar · View at Scopus
  36. E. di Carlo, C. Sorrentino, A. Zorzoli et al., “The antitumor potential of interleukin-27 in prostate cancer,” Oncotarget, vol. 5, no. 21, pp. 10332–10341, 2014. View at Google Scholar
  37. I. Airoldi and D. Ribatti, “Regulation of angiostatic chemokines driven by IL-12 and IL-27 in human tumors,” Journal of Leukocyte Biology, vol. 90, no. 5, pp. 875–882, 2011. View at Publisher · View at Google Scholar · View at Scopus
  38. M. Y. Ho, S. J. J. Leu, G. H. Sun, M. H. Tao, S. J. Tang, and K. H. Sun, “IL-27 directly restrains lung tumorigenicity by suppressing cyclooxygenase-2-mediated activities,” Journal of Immunology, vol. 183, no. 10, pp. 6217–6226, 2009. View at Publisher · View at Google Scholar · View at Scopus